Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1 antihistamine: A dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments

Journal of Clinical Psychopharmacology

Volumn 28, Issue 6, 2008, Pages 675-685

  García Gea, Consuelo ^a   Martínez Colomer, Joan ^a,b   Antonijoan, Rosa M ^a   Valiente, Román ^c   Barbanoj, Manuel José ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c FAES FARMA SA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BILASTINE; HISTAMINE; HYDROXYZINE; UNCLASSIFIED DRUG; BENZIMIDAZOLE DERIVATIVE; HISTAMINE H1 RECEPTOR ANTAGONIST; PIPERIDINE DERIVATIVE;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG ACTIVITY; DRUG EFFICACY; DRUG STRUCTURE; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; MALE; MOOD; NORMAL HUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; WEAKNESS; XEROSTOMIA; AFFECT; ATTENTION; CONTACT DERMATITIS; DOSE RESPONSE; DRUG EFFECT; INTRACUTANEOUS TEST; INTRADERMAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PERCEPTION; REACTION TIME; REFERENCE VALUE;

ADMINISTRATION, ORAL; ADULT; AFFECT; ATTENTION; BENZIMIDAZOLES; CROSS-OVER STUDIES; DERMATITIS, CONTACT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYDROXYZINE; INJECTIONS, INTRADERMAL; INTRADERMAL TESTS; MALE; PERCEPTION; PIPERIDINES; PSYCHOMOTOR PERFORMANCE; REACTION TIME; REFERENCE VALUES; YOUNG ADULT;

EID: 59049108204     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31818b2091     Document Type: Article

References (47)

1. Nicholson AN. Central effects of H1 and H2 antihistamines. Aviat Space Environ Med. 1985;56:293-298.
2. Meltzer EO. Performance effects of antihistamines. J Allergy Clin Immunol. 1990;86:613-619.
3. Roth T, Roehrs T, Koshorek G, et al. Sedative effects of antihistamines. J Allergy Clin Immunol. 1987;80:94-98.
4. Hindmarch I, Johnson S, Meadows R, et al. The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and ?are. Curr Med Res Opin. 2001;17:241-255.
5. Shamsi Z, Kimber S, Hindmarch I. An investigation into the effects of cetirizine on cognitive function and psychomotor performance in healthy volunteers. Eur J Clin Pharmacol. 2001;56:865-871.
6. Corcostegui R, Labeaga L, Innerarity A, et al. In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist. Drugs. 2006;7:219-231.
7. Corcostegui R, Labeaga L, Innerarity A, et al. Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity. Drugs. 2005;6: 371-384.
8. Levander S, Hagermark O, Stahle M. Peripheral antihistamine and central sedative effects of three H1-receptor antagonists. Eur J Clin Pharmacol. 1985;28:523-529.
9. Levander S, Stahle-Backdahl M, Hagermark O. Peripheral antihistamine and central sedative effects of single and continuous oral doses of cetirizine and hydroxyzine. Eur J Clin Pharmacol. 1991;41:435-439.
10. Blom MW, Bartel PR, Sommers DK, et al. The comparison of the effects of multi and single doses of buspirone, chlordiazepoxide and hydroxyzine on psychomotor function and EEG. Fundam Clin Pharmacol. 1992; 6:5-9.
11. Gandon JM, Allain H. Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drugs, on cognitive and psychomotor functions in healthy volunteers. Br J Clin Pharmacol. 2005; 54:51-58.
12. Walsh JK, Muehlbach MJ, Schweitzer PK. Simulated assembly line per- formance following ingestion of cetirizine or hydroxyzine. Ann Allergy. 1992;69:195-200.
13. Shamsi X, Hindmarch I. Sedation and antihistamines: a review of inter- drug differences using proportional impairment ratios. Hum Psycho-pharmacol Clin Exp. 2000;15:S3-S30.
14. Pechadre JC, Beudin P, Eschalier A, et al. A comparison of central and peripheral effects of cetirizine and loratadine. J Int Med Res. 1991;19: 289-295.
15. Schaaf L, Hendeles L, Weinberger M. Suppression of seasonal allergic rhinitis symptoms with daily hydroxyzine. J Allerg Clin Immunol. 1979; 63:129-133.
16. Druce HM. Seasonal allergic rhinitis and cognitive function. Ann Allergy Asthma Immunol. 2000;84:371-373.
17. Carruthers SG, Shoeman DW, Hignite CE, et al. Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin Pharmacol Ther. 1978;23:375-382.
18. Richards DM, Brogden RN, Heel RC, et al. Astemizole: a review of this pharmacodynamic properties and therapeutic ef?cacy. Drugs. 1984;28: 38-61.
19. Vincent J, Limiñana R, Meredith PA, et al. The pharmacokinetics, anti- histamine and concentration-effect relationship of ebastine in healthy subject. Br J Clin Pharmacol. 1988;26:497-501.
20. Barbanoj MJ, Garcéa-Gea C, Morte A, et al. Central and peripheral evaluation of rupatadine, a new antihistamine platelet-activating factor antagonist, at different doses in healthy volunteers. Neuropsychobiology. 2004;50:311-321.
21. Seidel WF, Cohen S, Bliwise N, et al. Cetirizine effects on objective measures of daytime sleepiness and performance. Ann Allergy Asthma Immunol. 1987;59:58-62.
22. Campoli-Richards DM, Buckley MMT, Fitton A. Cetirizine: a review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma and chronic urticaria. Drugs. 1990;40: 762-781.
23. Clarke CH, Nicholson AN. Performance studies on antihistamines. Br J Clin Pharmacol. 1978;6:31-35.
24. Gengo GM, Dabronzo J, Yurchak A, et al. The relative antihistaminic effects of hydroxyzine and cetirizine. Clin Pharmacol Ther. 1987;42: 265-272.
25. Pishkin V, Sengel RA, Lovallo WR, et al. Cognitive and psychomotor evaluation of clemastine, diphenhydramine HCl and hydroxyzine in a double-blind study. Curr Ther Res. 1983;33:230-247.
26. Burns M, Moskowitz H. Effects of diphenhydramine and alcohol on skills performance. Eur J Clin Pharmacol. 1980;17:259-266.
27. Seppala T, Nuotto E, Korttila K. Single and repeated dose comparison of three antihistamines and phenylpropanolamine psychomotor performance and subjective appraisal of sleep. Br J Clin Pharmacol. 1981; 12:179-188.
28. Richardson GS, Roehrs TA, Rosenthal L, et al. Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol. 2002;22: 511-515.
29. Vincent J, Summer DJ, Reig JL. Ebastine: the effect of a new anti- histamine on psychomotor performance and autonomic responses in healthy subjects. Br J Clin Pharmacol. 1988;26:503-508.
30. Nicholson AN, Stone BM. Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine. Br J Clin Pharmacol. 1982;1:199-202.
31. Weiner M. Sedation and antihistamines. Arzneimittelforschung. 1982;32: 1193-1195.
32. Barbanoj MJ, Garcéa-Gea C, Antonijoan R, et al. Evaluation of the cognitive, psychomotor and pharmacokinetic pro?les of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers. Hum Psychopharmacol Clin Exp. 2006;21:13-26.
33. Kulsrestha VK, Grupta PP, Turner P, et al. Some clinical pharmacological studies with terfenadine, a new antihistamine drug. Br J Clin Pharmacol. 1978;6:25-29.
34. Mattila MJ, Mattila M, Komo K. Acute and subacute actions on human performance and interactions with diazepam of temelastine (SK&F93944) and diphenhydramine. Eur J Clin Pharmacol. 1986;31: 291-298.
35. Bilzer W, Gundert-Remy U, Weber E. Relationship between antihistaminic activity and plasma levels of diphenhydramine. Eur J Clin Pharmacol. 1974;7:393-395.
36. Nelson HS, Knoetzer J, Bucher B. Effect of distance between sites and region of the body on results of skin prick tests. J Allergy Clin Immunol. 1996;97:596-601.
37. Skassa-Brociek W, Manderscheid JC, Michel FB, et al. Skin test reactivity to histamine from infancy to old age. J Allergy Clin Immunol. 1987;80:711-716.
38. Vermeeren A, Ramaekers G, O'Halon JF. Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females. J Psychopharmacol. 2002;16:57-64.
39. Demoly P, Michael FB, Bousquet J. In-vivo methods for study of allergy, skin tests: techniques and interpretation. In: Middleton E Jr, Reed C, Ellis EF, Yunginger JW, eds. Allergy: Principles and Practice. London, England: Mosby; 1998:430-439.
40. Barbanoj MJ, Antonijoan RM, Garcéa-Gea C, et al. A study comparing the inhibitory effects of single and repeated oral doses of ebastine and fexofenadine against histamine-induced skin reactivity. Int Arch Allergy Immunol. 2003;132:263-267.
41. Gisper J, Antonijoan R, Barbanoj M, et al. Ef?cacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges. Ann Allergy Asthma Immunol. 2002;89:259-264.
42. Hindmarch I. Psychomotor function and psychoactive drugs. Br J Clin Pharmacol. 1980;10:189-209.
43. Hindmarch I. Psychometric of drug effects in volunteers and patients. Pharm Med. 1988;3:135-142.
44. Barbanoj MJ, Lorenzo JL, Clos S, et al. Proof of safety of drugs: focus on vigilance. Methods Find Exp Clin Pharmacol. 2002;24(suppl C): 51-64.
45. Devillier P, Bousquet J. Inhibition of the histamine-reduced wheal and ?are response: a valid surrogate measure for antihistamine clinical ef?cacy. Clin Exp Allergy. 2007;37:400-414.
46. Cohen AF, Posner J, Ashby L, et al. A comparison of methods for assessing the sedative effects of diphenhydramine on skill related to car driving. Eur J Clin Pharmacol. 1984;27:477-482.
47. Vuurman E, Theunissen E, van Oers A, et al. Lack of effects between rupatadine 10 mg and placebo on actual driving performance of healthy volunteers. Hum Psychopharmacol Clin Exp. 2007;22:289-297.